1) renal cell carcinoma
肾癌
1.
Expression and significance of NF-κB and VEGF in renal cell carcinoma;
核因子κB和VEGF在肾癌中的表达及其意义
2.
The expression of COX-2 protein in renal cell carcinoma and its clinical value;
COX-2在肾癌中的表达及其临床意义
3.
Arsenic trioxide induces apoptosis of human renal cell carcinoma 786-0 cells;
As_2O_3诱导人肾癌786-0细胞凋亡及其分子机制的研究
2) Renal carcinoma
肾癌
1.
The analysis of perioperative risk factors of renal carcinoma in aged patients and the management;
高龄肾癌患者手术治疗的危险因素分析及防治
2.
Comparative study on the three ways to establish human renal carcinoma cell line subcutaneous xenograft models in nude mice;
3种建立人肾癌皮下荷瘤裸鼠模型方法比较
3.
Expression of KAI-1,Ki-67 and HER-2/neu on T_(1-3)N_0M_0 stage renal carcinoma(RC) and its significance to predict postoperative metastasis of RC;
KAI-1、Ki-67和HER-2/neu表达在T_(1-3)N_0M_0肾癌术后转移中的意义
3) Renal cancer
肾癌
1.
Purification and identification of heat shock protein 70 from human renal cancer tissue;
人肾癌组织中热休克蛋白70的纯化与鉴定分析
2.
Cinical value of pre-operative intervention treatment in advanced renal cancer;
中晚期肾癌术前介入治疗的临床价值
3.
Nephron sparing surger of ablation to renal cancer;
保留肾单位的肾癌消融治疗
4) kidney cancer
肾癌
1.
Clinical research of interventional treatment for 13 patients with kidney cancer;
13例肾癌病人介入治疗的临床分析
2.
Therapeutic efficacy of nanometer-high-frequency square pulse light technology targeting kidney cancer;
纳米-高频脉冲光技术靶向治疗肾癌的实验研究
3.
Approximately 40,000 new cases of kidney cancer will be diagnosed and about 13,000 people, including adults and children, will die from this disease in 2006 in the United States.
肾细胞癌是肾肿瘤中最常见的类型，占肾脏恶性肿瘤的90％以上，晚期的转移性肾癌对放疗与化疗均不敏感，一小部分患者对IL-2和IFN-α治疗有效，但药物的毒副作用十分明显。
5) RCC
肾癌
1.
To investigate whether tumor infiltrating lymphocytes (TIL) transfected with Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) and interleukin-2 (IL-2) genes is capable of improving the potency and efficiency of propagation and cytotoxicity against renal cell carcinoma (RCC) cells in vitro.
TRAIL联合IL-2转染肾癌TIL的研究 目的:研究从人肾癌组织中分离的肿瘤浸润性淋巴细胞(tumor infiltrating lymphocytes,TIL),在体外培养扩增后用肿瘤坏死因子相关凋亡配体(Tumor Necrosis Factor-related Apoptosis-inducing Ligand,TRAIL)联合白细胞介素-2(interleukin-2,IL-2)进行基因转染后能否增强TIL细胞的体外增殖能力和对自体肾癌细胞以及肾癌细胞系细胞(786-0)的体外杀伤活性。
2.
Background and ObjectiveRenal carcinoma, also called renal cell carcinoma (RCC), is one of the most common malignant renal parenchyma tumors.
【目的与背景】 肾癌又称肾细胞癌(renal rell carcinoma，RCC)，是泌尿生殖系统最常见的肾脏实质性恶性肿瘤之一，在我国泌尿生殖系统恶性肿瘤中发病率仅次于膀胱癌，占成人全身恶性肿瘤的3％左右。
3.
OBJECTIVE:With the development of the diagnosis technology,more and more renal cell carcinama(RCC)are found.
目的: 随着超声、CT检查的普及和健康查体的广泛开展,肾癌的诊出率较前明显增高。
6) Renal pelvic carcinoma
肾盂癌
1.
Laparoscopic nephroureterectomy for renal pelvic carcinoma:Report of 19 cases;
腹腔镜肾盂癌根治术19例分析
2.
【Results】62 cases of renal pelvic carcinoma,26 cases of ureteral carcinoma,and one case of ureteral stenosis were identified by the CT urography.
结果根据CT尿路造影诊断为肾盂癌62例、输尿管癌26例、输尿管狭窄1例,其中9例为多中心尿路上皮癌。
3.
Objective To invesigate the value of contrast-enhanced spiral CT scan in diagnosing renal pelvic carcinoma.
目的探讨螺旋CT增强扫描在肾盂癌诊断中的应用价值。
补充资料：肾癌
肾癌
carcinoma of kidney
即肾的恶性肿瘤，见"肾细胞癌"。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条